(Circulation. 1995;92:58-65.)
© 1995 American Heart Association, Inc.
Articles |
From the Cullen Cardiovascular Research Laboratories, Texas Heart Institute; Department of Adult Cardiology (E.B., S.W., W.H.M.), Texas Heart Institute/St Luke's Episcopal Hospital; and Baylor College of Medicine (S.W., W.H.M.), Houston, Tex.
Correspondence to Kamuran A. Kadipasaoglu, PhD, Texas Heart Institute, MC 1-268, PO Box 20345, Houston, TX 77225-0345.
Background We assessed the transmyocardial laser revascularization (TMLR) as sole therapy in patients with symptomatic coronary artery disease refractory to interventional or medical treatment.
Methods and Results Thirty-one patients were evaluated with positron emission tomography (PET), dobutamine echocardiography, 201Tl singlephoton emission computed tomography (201Tl-SPECT), and multigated acquisition radionuclide ventriculography (MUGA). TMLR was performed in 21 patients who had demonstrable ischemia in viable myocardium. The mean Canadian Cardiovascular Society (CCS) angina class was 3.70±0.7 (4 patients with unstable angina). Untreated septal segments were used as controls. At 3 months, (n=15 patients), the mean CCS angina class was to 2.43±0.9 (P<.05). On dobutamine echocardiography, the mean resting wall motion score index was improved by 16% in lased segments (P<.03 vs control), and mean LVEF at peak stress increased by 19% (P=NS vs baseline). On 201Tl-SPECT, perfusion of lased and nonlased segments did not change. On PET, the mean ratio of subendocardial to subepicardial perfusion (SEn/SEp) increased 14% over baseline (P<.001 vs control). At 6 months (n=15 patients), the mean CCS angina class was 1.7±0.8 (P<.05). The mean resting wall motion score index was up by 13% in lased segments (P<.05 vs control). Resting LVEF was unchanged. Stress LVEF increased 21% (P=NS vs baseline). Myocardial perfusion remained unchanged by 201Tl-SPECT. On PET, 36% of the lased segments were better, and 25% were worse compared with baseline. The resting SEn/SEp by PET was up 21% (P<.001 vs control). All deaths (two perioperative and three late) occurred in patients with preoperative congestive heart failure. Two patients required repeat revascularization of new coronary lesions.
Conclusions These results suggest that TMLR improves anginal status, relative endocardial perfusion, and cardiac function in patients who do not have preoperative congestive heart failure.
Key Words: lasers coronary disease ischemic revascularization myocardium
This article has been cited by other articles:
![]() |
K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text] |
||||
![]() |
J. Tasse and R. Arora Transmyocardial Revascularization: Peril and Potential Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 44 - 53. [Abstract] [PDF] |
||||
![]() |
S. Sirivella, I. Gielchinsky, and V. Parsonnet Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Ann. Thorac. Surg., November 1, 2005; 80(5): 1738 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meerkin, M. Pellerin, H. T. Aretz, P. Paiement, S. L. Houser, and R. Bonan Transmyocardial coil implants: a novel approach to transmyocardial revascularization Ann. Thorac. Surg., August 1, 2002; 74(2): 488 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schneider, A. Diegeler, R. Krakor, T. Walther, R. Kluge, and F.W. Mohr Transmyocardial laser revascularization with the holmium:YAG laser: loss of symptomatic improvement after 2 years Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 164 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bridges Myocardial laser revascularization: the controversy and the data Ann. Thorac. Surg., February 1, 2000; 69(2): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misfeld, K. Szabo, E.-G. Kraatz, M. Grossherr, C. Schmidtke, M. Pilgrim, W. Kuhnel, and H. H. Sievers Electron-microscopic findings after transmyocardial laser revascularization in an acute ischemic pig model Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 398 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kadipasaoglu, M. Sartori, T. Masai, H. B. Cihan, F. J. Clubb Jr, J. L. Conger, and O.H. Frazier Intraoperative arrhythmias and tissue damage during transmyocardial laser revascularization Ann. Thorac. Surg., February 1, 1999; 67(2): 423 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.M. Burns, L.D. Sharples, S. Tait, N. Caine, J. Wallwork, and P.M. Schofield The transmyocardial laser revascularization international registry report Eur. Heart J., January 1, 1999; 20(1): 31 - 37. [Abstract] [PDF] |
||||
![]() |
S. N. Oesterle Beyond stents: third-generation coronary devices Ann. Thorac. Surg., September 1, 1998; 66(3): 1045 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Pelletier, A. Giaid, S. Sivaraman, J. Dorfman, C. M. Li, A. Philip, and R. C.-J. Chiu Angiogenesis and growth factor expression in a model of transmyocardial revascularization Ann. Thorac. Surg., July 1, 1998; 66(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Milano, S. Pratali, G. Tartarini, R. Mariotti, M. De Carlo, G. Paterni, G. Boni, and U. Bortolotti Early Results of Transmyocardial Revascularization With a Holmium Laser Ann. Thorac. Surg., March 1, 1998; 65(3): 700 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kohmoto, P. E. Fisher, A. Gu, S.-M. Zhu, C. M. DeRosa, C. R. Smith, and D. Burkhoff Physiology, Histology, and 2-Week Morphology of Acute Transmyocardial Channels Made With a CO2 Laser Ann. Thorac. Surg., May 1, 1997; 63(5): 1275 - 1283. [Abstract] [Full Text] |
||||
![]() |
E. D. Jansen, M. Frenz, K. A. Kadipasaoglu, T. J. Pfefer, H. J. Altermatt, M. Motamedi, and A. J. Welch Laser-Tissue Interaction During Transmyocardial Laser Revascularization Ann. Thorac. Surg., March 1, 1997; 63(3): 640 - 647. [Abstract] [Full Text] |
||||
![]() |
K. J. Fleischer, P. J. Goldschmidt-Clermont, J. D. Fonger, G. M. Hutchins, R. H. Hruban, and W. A. Baumgartner One-Month Histologic Response of Transmyocardial Laser Channels With Molecular Intervention Ann. Thorac. Surg., October 1, 1996; 62(4): 1051 - 1058. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |